151 related articles for article (PubMed ID: 25929421)
1. Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.
Nesher L; Tverdek FP; Mahajan SN; Chemaly RF; Rolston KV
Infection; 2015 Oct; 43(5):545-50. PubMed ID: 25929421
[TBL] [Abstract][Full Text] [Related]
2. Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
Xu ZR; Ran XW; Xian Y; Yan XD; Yuan GY; Mu SM; Shen JF; Zhang BS; Gan WJ; Wang J
J Antimicrob Chemother; 2016 Jun; 71(6):1688-96. PubMed ID: 26888908
[TBL] [Abstract][Full Text] [Related]
3. Ertapenem: a review of its use in the treatment of bacterial infections.
Keating GM; Perry CM
Drugs; 2005; 65(15):2151-78. PubMed ID: 16225376
[TBL] [Abstract][Full Text] [Related]
4. The use of ertapenem for the treatment of lower extremity infections.
Nielsen MD; Mendicino RW; Catanzariti AR
J Foot Ankle Surg; 2009; 48(2):135-41. PubMed ID: 19232964
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of long-term outpatient ertapenem therapy.
Qureshi ZA; Syed A; Doi Y
Antimicrob Agents Chemother; 2014 Jun; 58(6):3437-40. PubMed ID: 24709258
[TBL] [Abstract][Full Text] [Related]
7. [Adequacy of treatment with ertapenem according to the criterion approved for the infection´s commission of a specialty hospital].
Manzano-García M; Márquez-Saavedra E
Rev Esp Quimioter; 2016 Aug; 29(4):195-201. PubMed ID: 27305510
[TBL] [Abstract][Full Text] [Related]
8. Ertapenem therapy for pneumonia requiring hospital admission in elderly people.
Artero A; Atienza A; Correa S; López I; Faus A; Puchades F; Madrazo M
Rev Esp Quimioter; 2016 Feb; 29(1):8-14. PubMed ID: 26837660
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Namias N; Solomkin JS; Jensen EH; Tomassini JE; Abramson MA
Surg Infect (Larchmt); 2007 Feb; 8(1):15-28. PubMed ID: 17381394
[TBL] [Abstract][Full Text] [Related]
10. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Teng CP; Chen HH; Chan J; Lye DC
Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
[TBL] [Abstract][Full Text] [Related]
11. Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
Yellin AE; Johnson J; Higareda I; Congeni BL; Arrieta AC; Fernsler D; West J; Gesser R
Am J Surg; 2007 Sep; 194(3):367-74. PubMed ID: 17693284
[TBL] [Abstract][Full Text] [Related]
12. Aztreonam for febrile neutropenia in patients with beta-lactam allergy.
McCullough BJ; Wiggins LE; Richards A; Klinker K; Hiemenz JW; Wingard JR
Transpl Infect Dis; 2014 Feb; 16(1):145-52. PubMed ID: 24119095
[TBL] [Abstract][Full Text] [Related]
13. Drug interaction between tacrolimus and ertapenem in renal transplantation recipients.
Bora F; Aliosmanoglu I; Kocak H; Dinckan A; Uslu HB; Gunseren F; Suleymanlar G
Transplant Proc; 2012 Dec; 44(10):3029-32. PubMed ID: 23195020
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration.
Sharara AI; El Hajj II; Mroueh M; Kyriacos SB; Abdul-Baki H; Chaar HF; Aoun E; Hashash JG; Mansour NM; Kanj SS
South Med J; 2011 Mar; 104(3):189-94. PubMed ID: 21297547
[TBL] [Abstract][Full Text] [Related]
15. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
[TBL] [Abstract][Full Text] [Related]
16. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
17. Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.
Trad MA; Zhong LH; Llorin RM; Tan SY; Chan M; Archuleta S; Sulaiman Z; Tam VH; Lye DC; Fisher DA
J Chemother; 2017 Feb; 29(1):25-29. PubMed ID: 27239695
[TBL] [Abstract][Full Text] [Related]
18. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
19. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.
Nix DE; Majumdar AK; DiNubile MJ
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii23-8. PubMed ID: 15150180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
